# Ashima Gulati

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ashima-gulati/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,447 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 25 |
| i10-index | 37 |
| Last Known Institution | University of Oxford |
| OpenAlex ID | https://openalex.org/A5048610534 |
| ORCID iD | 0000-0001-8625-9854 |
| Works | 75 |

## Researcher papers

- [Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children](https://scholariq.org/papers/prompt-plasma-exchanges-and-immunosuppressive-treatment-improves-the-outcomes-of/)
- [Isolated polycystic liver disease genes define effectors of polycystin-1 function](https://scholariq.org/papers/isolated-polycystic-liver-disease-genes-define-effectors-of-polycystin-1/)
- [Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome](https://scholariq.org/papers/efficacy-and-safety-of-treatment-with-rituximab-for-difficult-steroid-resistant/)
- [ALG9 Mutation Carriers Develop Kidney and Liver Cysts](https://scholariq.org/papers/alg9-mutation-carriers-develop-kidney-and-liver-cysts/)
- [Beyond the exome: What’s next in diagnostic testing for Mendelian conditions](https://scholariq.org/papers/beyond-the-exome-what-s-next-in-diagnostic-testing-for-mendelian-conditions/)
- [Overall Neutralization of Complement Factor H by Autoantibodies in the Acute Phase of the Autoimmune Form of Atypical Hemolytic Uremic Syndrome](https://scholariq.org/papers/overall-neutralization-of-complement-factor-h-by-autoantibodies-in-the-acute/)
- [Daily Corticosteroids Reduce Infection-associated Relapses in Frequently Relapsing Nephrotic Syndrome](https://scholariq.org/papers/daily-corticosteroids-reduce-infection-associated-relapses-in-frequently/)
- [Incidence of acute kidney injury in hospitalized children](https://scholariq.org/papers/incidence-of-acute-kidney-injury-in-hospitalized-children/)
- [Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome](https://scholariq.org/papers/treatment-with-tacrolimus-and-prednisolone-is-preferable-to-intravenous/)
- [Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome](https://scholariq.org/papers/efficacy-and-safety-of-rituximab-in-children-with-difficult-to-treat-nephrotic/)
- [Vascular Complications in Autosomal Dominant Polycystic Kidney Disease: Perspectives, Paradigms, and Current State of Play](https://scholariq.org/papers/vascular-complications-in-autosomal-dominant-polycystic-kidney-disease/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Researcher university

- [University of Oxford](https://scholariq.org/institutions/university-of-oxford/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.